Literature DB >> 20960910

[Remifentanil is useful for cardiovascular stability during cesarean delivery in a parturient with Marfan's syndrome].

Yuki Miyawaki1, Tomoko Yumiba, Takehiko Asaga, Satoshi Taie, Gotaro Shirakami.   

Abstract

A 25-year-old parturient with Marfan's syndrome was scheduled for cesarean delivery. She suffered with severe scoliosis and asymptomatic aortic root dilatation. To establish a cardiovascular stability and prevent aortic dissection perioperatively, we selected the use of remifentanil, an ultra-short acting opioid analgesic with general anesthesia. General anesthesia was induced with remifentanil (0.2 microg x kg(-1) x min(-1)), propofol (100 mg), and vecuronium bromide (10 mg). Anesthesia was maintained with 100% O2, sevoflurane (1-1.5%), and remifentanil (0.2-0.25 microg x kg(-1) x min(-1)). She remained hemodynamically stable during surgery. A lively infant was delivered and Apgar scores were 8 and 9 at 1 and 5 min, respectively. Their post-delivery courses were uneventful. Remifentanil was useful for anesthetic management in a pregnant patient with Marfan's syndrome undergoing cesarean delivery, although attention to infant's respiratory condition should be paid because remifentanil can cross the placenta.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960910

Source DB:  PubMed          Journal:  Masui        ISSN: 0021-4892


  1 in total

1.  Remifentanil at induction of general anesthesia for cesarean section: Double blind,randomized clinical trial.

Authors:  Shekoufeh Behdad; Vida Ayatollahi; Hamid Harrazi; Naderali Nazemian; Najmeh Heiranizadeh; Behnam Baghianimoghadam
Journal:  Colomb Med (Cali)       Date:  2013-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.